<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36725436</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2518</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>17</Day></PubDate></JournalIssue><Title>Vaccine</Title><ISOAbbreviation>Vaccine</ISOAbbreviation></Journal><ArticleTitle>Impact of COVID-19 vaccination in post-COVID cardiac complications.</ArticleTitle><Pagination><StartPage>1524</StartPage><EndPage>1528</EndPage><MedlinePgn>1524-1528</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2023.01.052</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0264-410X(23)00084-1</ELocationID><Abstract><AbstractText Label="BACKGROUND">After the acute infection, COVID-19 can produce cardiac complications as well as long-COVID persistent symptoms. Although vaccination against COVID-19 represented a clear reduction in both mortality and ICU admissions, there is very little information on whether this was accompanied by a decrease in the prevalence of post-COVID cardiac complications. The aim of this study was to analyze the relationship between COVID-19 vaccination and the prevalence of post-COVID cardiac injury assessed by echocardiogram, and long-COVID persistent cardiac symptoms.</AbstractText><AbstractText Label="METHODS">All patients who consulted for post-COVID evaluation 14 days after discharge from acute illness were included. Patients with heart disease were excluded. The relationship between complete vaccination scheme (at least two doses applied with 14 days or more since the last dose) and pathological echocardiographic findings, as well as the relationship of vaccination with persistent long-COVID symptoms, were evaluated by multivariate analysis, adjusting for age, sex and clinical variables that would have shown significant differences in univariate analysis.</AbstractText><AbstractText Label="RESULTS">From 1883 patients, 1070 patients (56.8%) suffered acute COVID-19 without a complete vaccination scheme. Vaccination was associated with lower prevalence of cardiac injury (1.35% versus 4.11%, adjusted OR 0.33; 95% CI 0.17-0.65, p=0.01). In addition, vaccinated group had a lower prevalence of persistent long-COVID symptoms compared to unvaccinated patients (10.7% versus 18.3%, adjusted OR 0.52; 95% CI 0.40-0.69, p&lt;0.001).</AbstractText><AbstractText Label="CONCLUSION">Vaccination against COVID-19 was associated with lower post-COVID cardiac complications and symptoms, reinforcing the importance of fully vaccinating the population.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Parodi</LastName><ForeName>Josefina B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Instituto Cardiovascular Lezica, Buenos Aires, Argentina. Electronic address: josefinab.parodi@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Indavere</LastName><ForeName>Agust&#xed;n</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Instituto Cardiovascular Lezica, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bobadilla Jacob</LastName><ForeName>Pamela</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Instituto Cardiovascular Lezica, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toledo</LastName><ForeName>Guillermo C</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>Instituto Cardiovascular Lezica, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Micali</LastName><ForeName>Rub&#xe9;n G</ForeName><Initials>RG</Initials><AffiliationInfo><Affiliation>Instituto Cardiovascular Lezica, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waisman</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Instituto Cardiovascular Lezica, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masson</LastName><ForeName>Walter</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Hospital Italiano de Buenos Aires, Ciudad Aut&#xf3;noma de Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Epstein</LastName><ForeName>Eduardo D</ForeName><Initials>ED</Initials><AffiliationInfo><Affiliation>Instituto Cardiovascular Lezica, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huerin</LastName><ForeName>Melina S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Instituto Cardiovascular Lezica, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Vaccine</MedlineTA><NlmUniqueID>8406899</NlmUniqueID><ISSNLinking>0264-410X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="Y">Heart Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Echocardiography</Keyword><Keyword MajorTopicYN="N">Myocarditis</Keyword><Keyword MajorTopicYN="N">Post-acute COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Vaccination</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>1</Day><Hour>22</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36725436</ArticleId><ArticleId IdType="pmc">PMC9885297</ArticleId><ArticleId IdType="doi">10.1016/j.vaccine.2023.01.052</ArticleId><ArticleId IdType="pii">S0264-410X(23)00084-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wu F., Zhao S., Yu B., Chen Y.M., Wang W., Song Z.G., et al. A new coronavirus associated with human respiratory disease in China. Nat. 2020;579:265&#x2013;269. doi: 10.1038/s41586-020-2008-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2008-3</ArticleId><ArticleId IdType="pmc">PMC7094943</ArticleId><ArticleId IdType="pubmed">32015508</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. WHO coronavirus disease (COVID-19) dashboard; 2023. https://covid19.who.int/ [accessed 12 Enero2023].</Citation></Reference><Reference><Citation>Guzik T.J., Mohiddin S.A., Dimarco A., Patel V., Savvatis K., Marelli-Berg F.M., et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116:1666&#x2013;1687. doi: 10.1093/cvr/cvaa106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa106</ArticleId><ArticleId IdType="pmc">PMC7197627</ArticleId><ArticleId IdType="pubmed">32352535</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W.J., Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708&#x2013;1720. doi: 10.1056/NEJMoa2002032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>T, Hoang, T, Tran Thi Anh Comparison of Comorbidities in Relation to Critical Conditions among Coronavirus Disease 2019 Patients: A Network Meta-Analysis. Infect Chemother. 2021;53:13-28. https://doi.org/10.3947/ic.2020.0136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8032911</ArticleId><ArticleId IdType="pubmed">34409779</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Madhavan M.V., Sehgal K., Nair N., Mahajan S., Sehrawat T.S., et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26:1017&#x2013;1032. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28:583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Martin S., Shchendrygina A., Hoffmann J., Ka M.M., Giokoglu E., et al. Long-term cardiac pathology in individuals with mild initial COVID-19 illness. Nat Med. 2022;28(10):2117&#x2013;2123. doi: 10.1038/s41591-022-02000-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02000-0</ArticleId><ArticleId IdType="pmc">PMC9556300</ArticleId><ArticleId IdType="pubmed">36064600</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Center for disease Control and Prevention (CDC). Long COVID or Post-COVID Conditions; 2022. https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html#:&#x223c;:text=People%20with%20post%2DCOVID%20conditions%20(or%20long%20COVID)%20may,away%20or%20come%20back%20again. [accessed 11 July 2022].</Citation></Reference><Reference><Citation>Raman B., Bluemke D.A., L&#xfc;scher T.F., Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. 2022;43:1157&#x2013;1172. doi: 10.1093/eurheartj/ehac031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>S, Shi, M, Qin, B, Shen, Y, Cai, T, Liu, F, Yang et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802-810. https:// doi.org/10.1001/jamacardio.2020.0950.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Lala A., Johnson K.W., Januzzi J.L., Russak A.J., Paranjpe I., Richter F., et al. Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection. J Am Coll Cardiol. 2020;76:533&#x2013;546. doi: 10.1016/j.jacc.2020.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.06.007</ArticleId><ArticleId IdType="pmc">PMC7279721</ArticleId><ArticleId IdType="pubmed">32517963</ArticleId></ArticleIdList></Reference><Reference><Citation>Madjid M., Safavi-Naeini P., Solomon S.D., Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020;5:831&#x2013;840. doi: 10.1001/jamacardio.2020.1286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1286</ArticleId><ArticleId IdType="pubmed">32219363</ArticleId></ArticleIdList></Reference><Reference><Citation>JY, Kim, K, Han, YJ, Suh, Prevalence of abnormal cardiovascular magnetic resonance findings in recovered patients from COVID-19: a systematic review and meta-analysis. J. Cardiovasc. Magn. Reson. 2021;23:100. https:// doi.org/10.1186/s12968-021-00792-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8414035</ArticleId><ArticleId IdType="pubmed">34479603</ArticleId></ArticleIdList></Reference><Reference><Citation>Parodi J.B., Bobadilla Jacob P., Toledo G.C., Micali R.G., Iacino M.P., Sotelo B., et al. Compromiso card&#xed;aco y su relaci&#xf3;n con la gravedad del cuadro agudo y los s&#xed;ntomas persistentes en la convalecencia de infecci&#xf3;n por COVID-19. Rev argent cardiol. 2021;89:332&#x2013;339. doi: 10.7440/res64.2018.03.</Citation><ArticleIdList><ArticleId IdType="doi">10.7440/res64.2018.03</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Qin C., Liu M., Liu J. Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis. Infect Dis Poverty. 2021;10:132. doi: 10.1186/s40249-021-00915-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-021-00915-3</ArticleId><ArticleId IdType="pmc">PMC8590867</ArticleId><ArticleId IdType="pubmed">34776011</ArticleId></ArticleIdList></Reference><Reference><Citation>G, Marrone, N, Nicolay, N, Bundle, T, Karki, G, Spiteri, H, Suija et al. Risk reduction of severe outcomes in vaccinated COVID-19 cases: an analysis of surveillance data from Estonia, Ireland, Luxembourg and Slovakia, January to November 2021. Euro Surveill. 2022;27:2200060. https:// doi.org/10.2807/1560-7917.ES.2022.27.7.2200060.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8855507</ArticleId><ArticleId IdType="pubmed">35177166</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronavirus. Definiciones y Clasificaci&#xf3;n de caso. Ministerio de Salud; Presidencia de la Naci&#xf3;n; 2021. https://www.argentina.gob.ar/salud/coronavirus/definicion-de-caso. [accessed 31 December 2021].</Citation></Reference><Reference><Citation>Coronavirus. M&#xe1;s preguntas sobre el pase sanitario. Ministerio de Salud; Presidencia de la Naci&#xf3;n; 2022. https://www.argentina.gob.ar/salud/mas-preguntas-sobre-pase-sanitario#:&#x223c;:text=Volver%20al%20%C3%ADndice-,5.,desde%20la%20%C3%BAltima%20dosis%20aplicada. [accessed 14 January 2023].</Citation></Reference><Reference><Citation>Coronavirus. &#xbf;Cu&#xe1;les vacunas estamos aplicando en el pa&#xed;s? Ministerio de Salud; Presidencia de la Naci&#xf3;n; 2021. https://www.argentina.gob.ar/coronavirus/vacuna/cuales [accessed 21 September 2021].</Citation></Reference><Reference><Citation>Lang R.M., Badano L.P., Mor-Avi V., Afilalo J., Armstrong A., Ernande L., et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the american society of echocardiography and the european association of cardiovascular imaging. J Am Soc Echocardiogr. 2015;28:1&#x2013;39.e14. doi: 10.1093/ehjci/jev014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jev014</ArticleId><ArticleId IdType="pubmed">25559473</ArticleId></ArticleIdList></Reference><Reference><Citation>D, Lindner, A, Fitzek, H, Br&#xe4;uninger, G, Aleshcheva, C, Edler, K, Meissner et al. Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases.&#xa0;JAMA Cardiol.&#xa0;2020;5:1281-1285. https:// doi.org/10.1001/jamacardio.2020.3551.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385672</ArticleId><ArticleId IdType="pubmed">32730555</ArticleId></ArticleIdList></Reference><Reference><Citation>M, Hoffmann, H, Kleine-Weber, S, Schroeder, N, Kruger, T, Herrler, S, Erichsen et al.&#xa0;SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor.&#xa0;Cell&#xa0;2020. Cell. 2020;181:271-280. https://doi.org/10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu P.P., Blet A., Smyth D., Li H. The Science Underlying COVID-19: Implications for the Cardiovascular System. Circulation. 2020;142:68&#x2013;78. doi: 10.1161/CIRCULATIONAHA.120.047549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047549</ArticleId><ArticleId IdType="pubmed">32293910</ArticleId></ArticleIdList></Reference><Reference><Citation>Siripanthong B., Nazarian S., Muser D., Deo R., Santangeli P., Khanji M.Y., et al. Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 2020;17:1463&#x2013;1471. doi: 10.1016/j.hrthm.2020.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2020.05.001</ArticleId><ArticleId IdType="pmc">PMC7199677</ArticleId><ArticleId IdType="pubmed">32387246</ArticleId></ArticleIdList></Reference><Reference><Citation>VO, Puntmann, ML, Carerj, I, Wieters, M, Fahim, C, Arendt, J, Hoffmann et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5:1265-1273. https:// doi.org/10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Barssoum K., Victor V., Salem A., Kumar A., Mubasher M., Hassib M., et al. Echocardiography, lung ultrasound, and cardiac magnetic resonance findings in COVID-19: a systematic review. Echocardiography. 2021;38:1365&#x2013;1404. doi: 10.1111/echo.15152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/echo.15152</ArticleId><ArticleId IdType="pmc">PMC8444724</ArticleId><ArticleId IdType="pubmed">34236091</ArticleId></ArticleIdList></Reference><Reference><Citation>Zisis S.N., Durieux J.C., Mouchati C., Perez J.A., McComsey G.A. The Protective Effect of Coronavirus Disease 2019 (COVID-19) Vaccination on Postacute Sequelae of COVID-19: a multicenter study from a large national health research network. open forum. Infect Dis. 2022;9:ofac228. doi: 10.1093/ofid/ofac228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac228</ArticleId><ArticleId IdType="pmc">PMC9129153</ArticleId><ArticleId IdType="pubmed">35818362</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond) 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Mumtaz A., Sheikh A.A.E., Khan A.M., Khalid S.N., Khan J., Nasrullah A., et al. COVID-19 Vaccine and Long COVID: a Scoping Review. Life (Basel) 2022;12:1066. doi: 10.3390/life12071066.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12071066</ArticleId><ArticleId IdType="pmc">PMC9324565</ArticleId><ArticleId IdType="pubmed">35888154</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynberg E., Han A.X., Boyd A., van Willigen H.D.G., Verveen A., Lebbink R., et al. The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): a prospective cohort study. Vaccine. 2022;40:4424&#x2013;4431. doi: 10.1016/j.vaccine.2022.05.090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.05.090</ArticleId><ArticleId IdType="pmc">PMC9170535</ArticleId><ArticleId IdType="pubmed">35725782</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherlinger M., Pijnenburg L., Chatelus E., Arnaud L., Gottenberg J.E., Sibilia J., et al. Effect of SARS-CoV-2 Vaccination on Symptoms from Post-Acute Sequelae of COVID-19: results from the Nationwide VAXILONG Study. Vaccines (Basel) 2021;10:46. doi: 10.3390/vaccines10010046.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10010046</ArticleId><ArticleId IdType="pmc">PMC8781023</ArticleId><ArticleId IdType="pubmed">35062706</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozkurt B., Kamat I., Hotez P. Myocarditis with COVID-19 mRNA vaccines. Circulation. 2021;144:471&#x2013;484. doi: 10.1161/CIRCULATIONAHA.121.056135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.056135</ArticleId><ArticleId IdType="pmc">PMC8340726</ArticleId><ArticleId IdType="pubmed">34281357</ArticleId></ArticleIdList></Reference><Reference><Citation>Barda N., Dagan N., Ben-Shlomo Y., Kepten E., Waxman J., Ohana R., et al. Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting. N Engl J Med. 2021;385:1078&#x2013;1090. doi: 10.1056/NEJMoa2110475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2110475</ArticleId><ArticleId IdType="pmc">PMC8427535</ArticleId><ArticleId IdType="pubmed">34432976</ArticleId></ArticleIdList></Reference><Reference><Citation>Simone A., Herald J., Chen A., Gulati N., Shen A.Y., Lewin B., et al. Acute Myocarditis Following COVID-19 mRNA vaccination in adults aged 18 years or older. JAMA Intern Med. 2021;181:1668&#x2013;1670. doi: 10.1001/jamainternmed.2021.5511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2021.5511</ArticleId><ArticleId IdType="pmc">PMC8491129</ArticleId><ArticleId IdType="pubmed">34605853</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein N.P., Lewis N., Goddard K., Fireman B., Zerbo O., Hanson K.E., et al. Surveillance for adverse events After COVID-19 mRNA Vaccination. JAMA. 2021;326:1390&#x2013;1399. doi: 10.1001/jama.2021.15072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.15072</ArticleId><ArticleId IdType="pmc">PMC8511971</ArticleId><ArticleId IdType="pubmed">34477808</ArticleId></ArticleIdList></Reference><Reference><Citation>Patone M., Mei X.W., Handunnetthi L., Dixon S., Zaccardi F., Shankar-Hari M., et al. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat Med. 2022;28:410&#x2013;422. doi: 10.1038/s41591-021-01630-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01630-0</ArticleId><ArticleId IdType="pmc">PMC8863574</ArticleId><ArticleId IdType="pubmed">34907393</ArticleId></ArticleIdList></Reference><Reference><Citation>JI, Irassar, E, Bartel, D, Obando, T, Varela COMPARACI&#xd3;N EPIDEMIOL&#xd3;GICA DE LAS OLAS POR COVID-19 EN LA PROVINCIA DE BUENOS AIRES, ARGENTINA, 2020-2021. Rev. argent. salud p&#xfa;blica [Internet]. 2022; 14:49-49. http://www.scielo.org.ar/scielo.php?script=sci_arttext&amp;pid=S1853-810X2022000200049&amp;lng=es. [accessed 15 January 2023].</Citation></Reference><Reference><Citation>Coronavirus. Informaci&#xf3;n Epidemiol&#xf3;gica. Ministerio de Salud; Presidencia de la Naci&#xf3;n; 2023. https://www.argentina.gob.ar/salud/coronavirus-COVID-19/sala-situacion. [accessed 15 January 2023].</Citation></Reference><Reference><Citation>Coronavirus. Informaci&#xf3;n Epidemiol&#xf3;gica. Ministerio de Salud; Presidencia de la Naci&#xf3;n; 2021. https://www.argentina.gob.ar/noticias/vigilancia-de-variantes-de-sars-cov-2-en-caba-provincia-de-buenos-aires-cordoba-entre-rios. [accessed 15 January 2023].</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>